Literature DB >> 24385002

Molecular characterisation of Escherichia coli isolated from hospitalised children and adults with urinary tract infection.

T L Vollmerhausen1, M Katouli.   

Abstract

Urinary tract infection (UTI) is common amongst children and recurs in 10-30 % of cases. The differences between Escherichia coli strains causing UTI among hospitalised children and adults remains to be fully elucidated. Here, we examined the genetic relatedness and virulence gene (VG) profiles of a collection of E. coli causing UTI among hospitalised children and adults. Genetic relatedness among the strains was investigated using random amplified polymorphic DNA (RAPD) analysis and the strains were characterised using a combination of phylogenetic grouping, the ability to form biofilm and the presence of antigen 43 (Ag43) and its five known alleles, as well 20 VGs associated with uropathogenic E. coli (UPEC). RAPD analysis resolved six major clusters, with two clusters (A and B) consisting almost exclusively of E. coli isolated from children. Isolates from children had a higher prevalence of alpha-haemolysin (hlyA, p < 0.05) and group II capsular polysaccharide synthesis genes (kpsMT II, p < 0.01) than adults. In contrast, E. coli strains from adults had a higher prevalence of invasive ibeA (p < 0.05) and Ag43 (agn43) (p < 0.05) genes, and produced significantly (p < 0.001) more biofilm than E. coli from children. Adult isolates also carried significantly (p < 0.05) more agn43 allele RS218 compared to isolates from children, which carried significantly (p < 0.05) more of the agn43 allele bCFT073. Our results suggest that bacterial virulence factors play an important role in UTI among hospitalised children; however, further research will determine whether these findings apply to a larger cohort and other clinical settings for UTI in children and adults.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24385002     DOI: 10.1007/s10096-013-2035-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  46 in total

1.  Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis.

Authors:  James R Johnson; Michael A Kuskowski; Timothy T O'bryan; Raul Colodner; Raul Raz
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

2.  Decoctions from Citrus reticulata Blanco seeds protect the uroepithelium against Escherichia coli invasion.

Authors:  Tara L Vollmerhausen; Nubia L Ramos; Dang Thi Ngoc Dzung; Annelie Brauner
Journal:  J Ethnopharmacol       Date:  2013-10-09       Impact factor: 4.360

3.  Ongoing horizontal and vertical transmission of virulence genes and papA alleles among Escherichia coli blood isolates from patients with diverse-source bacteremia.

Authors:  J R Johnson; T T O'Bryan; M Kuskowski; J N Maslow
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

Review 4.  Pathogenesis of urinary tract infection: an update.

Authors:  Robert H Mak; Huey-Ju Kuo
Journal:  Curr Opin Pediatr       Date:  2006-04       Impact factor: 2.856

Review 5.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

6.  Clinical Escherichia coli isolates utilize alpha-hemolysin to inhibit in vitro epithelial cytokine production.

Authors:  David W Hilbert; Teresa E Paulish-Miller; Chee K Tan; Alison J Carey; Glen C Ulett; Eli Mordechai; Martin E Adelson; Scott E Gygax; Jason P Trama
Journal:  Microbes Infect       Date:  2012-01-25       Impact factor: 2.700

Review 7.  Prevention of recurrent urinary tract infection in children.

Authors:  Gabrielle Williams; Jonathan C Craig
Journal:  Curr Opin Infect Dis       Date:  2009-02       Impact factor: 4.915

Review 8.  Epidemiology of urinary tract infections: incidence, morbidity, and economic costs.

Authors:  Betsy Foxman
Journal:  Am J Med       Date:  2002-07-08       Impact factor: 4.965

9.  Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract.

Authors:  Glen C Ulett; Jaione Valle; Christophe Beloin; Orla Sherlock; Jean-Marc Ghigo; Mark A Schembri
Journal:  Infect Immun       Date:  2007-04-09       Impact factor: 3.441

Review 10.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

View more
  5 in total

1.  Genetic diversity and virulence characteristics of biofilm-producing uropathogenic Escherichia coli.

Authors:  Ali Qasemi; Fateh Rahimi; Mohammad Katouli
Journal:  Int Microbiol       Date:  2021-10-27       Impact factor: 2.479

Review 2.  Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies.

Authors:  Amelia E Barber; J Paul Norton; Travis J Wiles; Matthew A Mulvey
Journal:  Microbiol Mol Biol Rev       Date:  2016-03-02       Impact factor: 11.056

3.  Invasion and translocation of uropathogenic Escherichia coli isolated from urosepsis and patients with community-acquired urinary tract infection.

Authors:  B Owrangi; N Masters; A Kuballa; C O'Dea; T L Vollmerhausen; M Katouli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-16       Impact factor: 3.267

4.  Incorporation of Actinobacillus pleuropneumoniae in Preformed Biofilms by Escherichia coli Isolated From Drinking Water of Swine Farms.

Authors:  Flor Y Ramírez-Castillo; Abraham Loera-Muro; Nicy D Vargas-Padilla; Adriana C Moreno-Flores; Francisco J Avelar-González; Josée Harel; Mario Jacques; Ricardo Oropeza; Carolina C Barajas-García; Alma L Guerrero-Barrera
Journal:  Front Vet Sci       Date:  2018-08-14

5.  Clinical Epidemiology Characteristics and Antibiotic Resistance Associated with Urinary Tract Infections Caused by E. coli.

Authors:  Sang Ngoc Nguyen; Huyen Thanh Thi Le; Tam Duc Tran; Lam Tung Vu; Tho Huu Ho
Journal:  Int J Nephrol       Date:  2022-02-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.